AbCellera nabs Series B led by OrbiMed and DCVC Bio

Vancouver, British Columbia-based AbCellera, a biotech company, has raised US$105 million in Series B financing.

27 May 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles